Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices

Annals of Hepatology

Volumn 9, Issue 1, 2010, Pages 15-22

  Pérez Ayuso, Rosa María ^a   Valderrama, Sebastián ^a   Espinoza, Manuel ^a,b   Rollán, Antonio ^b   Sánchez, René ^c   Otarola, Francisco ^a   Medina, Brenda ^a   Riquelme, Arnoldo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DEL DESARROLLO   (Chile)

^c HOSPITAL DR SÓTERO DEL RÍO   (Chile)

Author keywords

Beta blockers; Cirrhosis; Endoscopic band ligation; Primary prophylaxis; Propranolol; Randomized controlled trial; Variceal bleeding

Indexed keywords

PROPRANOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEATH; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; DYSPHAGIA; DYSPNEA; ENDOSCOPIC BAND LIGATION; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES BLEEDING; FEMALE; HIGH RISK PATIENT; HUMAN; LIGATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; ODYNOPHAGIA; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENDOSCOPY; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; AGED; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; KAPLAN-MEIERS ESTIMATE; LIGATION; MALE; MIDDLE AGED; PROPRANOLOL; RISK FACTORS; TREATMENT OUTCOME;

EID: 77954570954     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31674-6     Document Type: Article

References (30)

1. Pagliaro L, D'Amico G, Pasta L, Politi F, Vizzini G, Traina M, et al. Portal hypertension in cirrhosis: Natural history. In: Bosch J, Groszmann RJ (eds.). Portal Hypertension. Pa-thophysiology and Treatment. Oxford, UK: Blackwell Scientific; 1994, p. 72-92.
2. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first vari-ceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988; 319: 983-989.
3. D'Amico G, de Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612.
4. Carbonell N, Pauwels A, Serfaty L, Fourdan O, Levy VG, Poupon R. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepato-logy 2004; 40: 652-659.
5. Garcia-Tsao, Sanyan A, Grace N, Carey W. Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis. Hepatology 2007; 46: 922-938.
6. de Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J He-patol 2005; 43: 167-176.
7. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment ofportal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19: 475-505.
8. Bosch J, Mastai R, Kravetz D, Bruix J, Gaya J, Rigau J, et al. Effects of propranolol on azygos blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 1984; 4: 1200-1205.
9. Garcia-Tsao G, Grace ND, Groszmann RJ, Conn HO, Ber-mann MM, Patrick MJ, et al. Short-term effects of propra-nolol on portal venous pressure. Hepatology 1986; 6: 101-106.
10. Vorobioff J, Picabea E, Villavicencio R, Puccini V, Rossi O, Bordato J, et al. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatolo-gy 1987; 7:648-653.
11. Lui HF, Stanley AJ, Forrest EW, Jalan R, Hislop WS, Mills PR, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propra-nolol, and isosorbide mononitrate. Gastroenterology 2002; 123: 735-744.
12. Abraczinskas D, Ookubo R, Grace N, Groszmann R, Bosch J, Garcia-Tsao G, et al. Propranolol for the prevention of first variceal bleeding: a lifetime commitment? Hepatology 2001; 34: 1096-10102.
13. Lo GH, Lai KH, Cheng JS, Chen MH, Huang HC, Hsu PI, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of vari-ceal rebleeding: a prospective, randomized trial. Hepato-logy 2000; 32: 461-465.
14. De la Pena J, Brullet E, Sanchez-Hernandez E, Rivero M, Vergara M, Martin-Lorente JL, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of va-riceal rebleeding: a multicenter trial. Hepatology 2005; 41: 572-578.
15. Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, et al. Endoscopic ligation vs nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc 2004; 59: 333-338.
16. Schepke M, Kleber G, Nurnberg D, Willert J, Koch L, Veltzke-Schlieker W, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2004; 40: 65-72.
17. Song H, Shin JW, Kim HI, Choi J, Lim CY, Kim JW, et al. A prospective randomized trial between the prophylactic endoscopic variceal ligation and propranolol administration for prevention of first bleeding in cirrhotic patients with high risk esophageal varices. J Hepatol 2000; 32: 41A.
18. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999; 340: 988-993.
19. Jutabha R, Jensen DM, Martin P, Savides T, Han SH, Gor-nbein J. Randomized study comparing banding and propra-nolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology 2005; 128: 870-881.
20. Lui HF, Stanley AJ, Forrest EH, Jalan R, Hislop WS, Mills PR, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propra-nolol and isosorbide mononitrate. Gastroenterology 2002; 123: 735-744.
21. Norberto L, Polese L, Cillo U, Grigoletto F, Burroughs A, Neri D, et al. A randomized study comparing ligation with propra-nolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. Liver Transpl 2007; 13: 1272-1278.
22. De BK, Ghosghal UC, Das T, Santra A, Biswas PK. Endosco-pic variceal ligation for primary prophylaxis of esophageal variceal bleed: preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 1999; 14: 220-224.
23. de Franchis R. Updating consensus in portal hypertension: Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-852.
24. Garcia-Pagan JC, Bosch J. Endoscopic band ligation in the treatment of portal hypertension. Nat Clin Pract Gas-troenterol Hepatol 2005; 2: 526-535.
25. Khuroo MS, Khuroo NS, Farahat KL, Khuroo YS, Sofi AA, Da-hab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005; 21: 347-361.
26. Sarin SK, Guptan RKC, Jain AK, Sundaram KR. A randomized controlled trial of endocopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol and Hepatol 1996; 8: 337-342.
27. Chen CY, Sheu MZ, Su SY. Prophylactic endoscopic vari-ceal ligation with multiple band ligator for oesophageal va-rices. Gastroenterology 1998; 114: A1224.
28. De la Mora JG, Farca-Belsaguy AA, Uribe M, de Hoyos-Garza A. Ligation vs Propranolol for primary prophylaxis of va-riceal bleeding using multiple band ligator and objective measurements of treatment adequacy: preliminary results. Gastroenterology 2000; 118: A6511.
29. Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC. Endoscopic variceal ligation plus propranolol versus en-doscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 2005; 100: 797-804.
30. Abraldes JG, Tarantino I, Turnes J, García-Pagán JC, Ro-dés J, Bosch J. Hemodynamic response topharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003; 37: 902-908.